Hi-Line Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,982
| Closed | -$6.55M | – | 34 |
|
|
2024
Q1 | $6.55M | Buy |
35,982
+505
| +1% | +$92K | 2.33% | 15 |
|
|
2023
Q4 | $5.5M | Sell |
35,477
-3,419
| -9% | -$530K | 2.13% | 19 |
|
|
2023
Q3 | $5.8M | Sell |
38,896
-108
| -0.3% | -$16.1K | 2.14% | 19 |
|
|
2023
Q2 | $5.25M | Sell |
39,004
-4,685
| -11% | -$631K | 1.95% | 18 |
|
|
2023
Q1 | $6.96M | Sell |
43,689
-28,441
| -39% | -$4.53M | 2.38% | 18 |
|
|
2022
Q4 | $11.7M | Buy |
72,130
+216
| +0.3% | +$34.9K | 3.6% | 12 |
|
|
2022
Q3 | $9.66M | Buy |
71,914
+1,654
| +2% | +$222K | 3.89% | 12 |
|
|
2022
Q2 | $10.8M | Buy |
70,260
+1,760
| +3% | +$270K | 4.09% | 11 |
|
|
2022
Q1 | $11.1M | Buy |
68,500
+654
| +1% | +$106K | 3.79% | 11 |
|
|
2021
Q4 | $9.19M | Buy |
67,846
+80
| +0.1% | +$10.8K | 3.38% | 13 |
|
|
2021
Q3 | $7.31M | Buy |
67,766
+2,120
| +3% | +$229K | 2.61% | 16 |
|
|
2021
Q2 | $7.39M | Buy |
65,646
+259
| +0.4% | +$29.2K | 2.81% | 15 |
|
|
2021
Q1 | $7.08M | Buy |
+65,387
| New | +$7.08M | 2.83% | 15 |
|